Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03655015 · ClinicalTrials.gov registry record
Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
A clinical trial of Lung Neoplasm, sponsored by The University of Texas Health Science Center at San Antonio.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT03655015 is a study of Lung Neoplasm that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 150 participants, below the 537-participant average among 8 other Lung Neoplasm trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03655015, a study of Lung Neoplasm, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Create a living biobank of PDOs from Stage I-III lung cancer patients.
Conditions Studied
Interventions
- PROCEDURE Lung Tumor Resection
Study Locations (1)
Texas
- UT Health San Antonio, M.D. Anderson Cancer Center - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2018-10-16 |
| Est. Completion | 2029-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03655015
The ClinicalTrials.gov registry entry for NCT03655015 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 537-participant average among 8 other Lung Neoplasm trials with a reported enrollment target (72% lower). The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Lung Tumor Resection is the first listed.
NCT03655015 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03655015 about?
NCT03655015 is a clinical study titled "Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer". Create a living biobank of PDOs from Stage I-III lung cancer patients.
What is the current status of trial NCT03655015?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2018-10-16. Estimated completion is 2029-12.
What conditions does trial NCT03655015 study?
This clinical trial studies the following conditions: Lung Neoplasm.
What interventions are being tested in trial NCT03655015?
The interventions under investigation include: Lung Tumor Resection (PROCEDURE).
Who is sponsoring clinical trial NCT03655015?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03655015 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
RECRUITING · NA
-
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
RECRUITING · Phase 2
-
Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules
ACTIVE NOT RECRUITING · NA
-
Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma
ACTIVE NOT RECRUITING · NA
-
False/Negative Rate of Lung Percutaneous Needle Biopsy
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.